Barclays PLC Gilead Sciences, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Barclays PLC holds 114,600 shares of GILD stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

114,600

Previous 4,228,798 97.29%

Holding current value

$10.3 Million

Previous $355 Million 97.29%

% of portfolio

0.0%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$66.59 - $83.99 $28.5 Million - $35.9 Million	-427,594 Reduced 9.18%	4,228,798 $355 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $136 Million - $157 Million	-2,151,007 Reduced 31.6%	4,656,392 $319 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $80.7 Million - $98.4 Million	1,127,429 Added 19.85%	6,807,399 $499 Million
Q4 2023 Feb 15, 2024	BUY	$73.27 - $83.09 $136 Million - $155 Million	1,859,883 Added 48.69%	5,679,970 $460 Million
Q3 2023 Nov 07, 2023	SELL	$73.94 - $80.67 $209 Million - $228 Million	-2,822,823 Reduced 42.49%	3,820,087 $286 Million
Q2 2023 Aug 03, 2023	BUY	$76.01 - $86.7 $162 Million - $184 Million	2,126,182 Added 47.07%	6,642,910 $512 Million
Q1 2023 May 04, 2023	SELL	$77.31 - $88.08 $114 Million - $130 Million	-1,470,740 Reduced 24.56%	4,516,728 $375 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $258 Million - $370 Million	4,138,589 Added 223.84%	5,987,468 $514 Million
Q3 2022 Nov 03, 2022	SELL	$59.54 - $68.01 $17.5 Million - $19.9 Million	-293,188 Reduced 13.69%	1,848,879 $114 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $44.9 Million - $50.6 Million	-778,053 Reduced 26.64%	2,142,067 $132 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $141 Million - $177 Million	-2,440,498 Reduced 45.53%	2,920,120 $174 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $147 Million - $167 Million	2,272,720 Added 73.6%	5,360,618 $389 Million
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $26.8 Million - $29 Million	396,577 Added 14.74%	3,087,898 $216 Million
Q2 2021 Aug 13, 2021	BUY	$63.47 - $69.35 $2.8 Million - $3.06 Million	44,088 Added 1.67%	2,691,321 $185 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $47.6 Million - $54.3 Million	792,952 Added 42.76%	2,647,233 $171 Million
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $23.6 Million - $26.9 Million	416,094 Added 28.93%	1,854,281 $108 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $19 Million - $23.8 Million	305,188 Added 26.94%	1,438,187 $90.9 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $92.9 Million - $108 Million	-1,283,828 Reduced 53.12%	1,132,999 $87.2 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $31.2 Million - $39.9 Million	-497,581 Reduced 17.07%	2,416,827 $181 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $57.4 Million - $63.1 Million	-930,759 Reduced 24.21%	2,914,408 $189 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $66.4 Million - $73.3 Million	1,062,999 Added 38.21%	3,845,167 $244 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $10.2 Million - $11.5 Million	165,238 Added 6.31%	2,782,168 $188 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.34 Million - $1.5 Million	21,421 Added 0.83%	2,616,930 $170 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $25.1 Million - $32.7 Million	414,108 Added 18.98%	2,595,509 $162 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $6.8 Million - $7.53 Million	-95,433 Reduced 4.19%	2,181,401 $168 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $43.4 Million - $50.6 Million	-668,208 Reduced 22.69%	2,276,834 $161 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $15.2 Million - $18.5 Million	208,297 Added 7.61%	2,945,042 $222 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $50.8 Million - $59.6 Million	713,552 Added 35.27%	2,736,745 $196 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $146 Million - $173 Million	2,023,193	2,023,193 $164 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account